Recent developments in anti-herpesvirus drugs
2013; Oxford University Press; Volume: 106; Issue: 1 Linguagem: Inglês
10.1093/bmb/ldt011
ISSN1471-8391
AutoresHugh J. Field, R. Anthony Vere Hodge,
Tópico(s)Viral-associated cancers and disorders
ResumoBackgroundHerpesviruses notably establish lifelong infections, with latency and reactivation. Many of the known human herpesviruses infect large proportions of the population worldwide. Treatment or prevention of herpes infections and recurrent disease still pose a challenge in the 21st century.
Referência(s)